Top pharma and biotech conferences 2025
PharmaVoice
OCTOBER 1, 2024
Mark your calendars for the most important industry conferences in 2025.
PharmaVoice
OCTOBER 1, 2024
Mark your calendars for the most important industry conferences in 2025.
STAT
OCTOBER 4, 2024
That’s why the federal government expects enrollment in the $500 billion Medicare Advantage program to grow once again in 2025 — a stark contrast from insurers’ cries that modest payment reforms would damage them and seniors’ options.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
APRIL 11, 2024
billion in 2025, a spokesperson for the Centers for Medicare and Medicaid Services confirmed to STAT. Medicare’s actuaries expect the drug Leqembi , made by the Japanese drugmaker Eisai and sold in partnership with Biogen, to cost the traditional Medicare program around $550 million in 2024, and the entire Medicare program $3.5
Med Ed 101
OCTOBER 27, 2024
NABP recently released information on what to expect for those taking the NAPLEX exam on or after May 1st, 2025. There are some significant changes to the content outline and I outline those changes in the Youtube […] The post NAPLEX Changes in 2025: What Pharmacists Need to Know appeared first on Med Ed 101.
STAT
APRIL 1, 2024
The result: In 2025, right after a new president is elected, Medicare Advantage insurers will have to absorb a slight decrease of 0.2% to the baseline payment rates that insurers receive from the government for enrolling older adults and people with disabilities.
Pharma and Life Sciences Blog
NOVEMBER 14, 2024
GEP Outlook 2025 priyanka.katke… Thu, 11/14/2024 - 14:45 Drive Procurement and Supply Chain Success in 2025 For years, you and your team have fought an uphill battle. Supply disruptions. Cost pressures. ESG compliance. Geopolitical tensions. You name it, and you’ve had to navigate it.
BioPharma Dive
OCTOBER 1, 2024
Here’s a list of conferences to watch in 2025. Medical meetings often feature important clinical trial results, making them barometers of biotech and pharma companies' research progress.
Let's personalize your content